Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 47

Related Articles by Review for PubMed (Select 17874350)

1.

The influence of antipsychotic treatment on brain reward system reactivity in schizophrenia patients.

Kirsch P, Ronshausen S, Mier D, Gallhofer B.

Pharmacopsychiatry. 2007 Sep;40(5):196-8.

PMID:
17874350
2.

Review the role of dopamine D4 receptors in schizophrenia and antipsychotic action.

Sanyal S, Van Tol HH.

J Psychiatr Res. 1997 Mar-Apr;31(2):219-32. Review.

PMID:
9278187
3.

How do the atypical antipsychotics work?

Ananth J, Burgoyne KS, Gadasalli R, Aquino S.

J Psychiatry Neurosci. 2001 Nov;26(5):385-94. Review.

4.

Antipsychotic drug mechanisms and neurotransmitter systems in schizophrenia.

Reynolds GP.

Acta Psychiatr Scand Suppl. 1994;380:36-40. Review.

PMID:
7914046
5.

Atypical antipsychotics: mechanism of action.

Seeman P.

Can J Psychiatry. 2002 Feb;47(1):27-38. Review.

PMID:
11873706
6.

[Cognition, schizophrenia and the effect of antipsychotics].

Stip E.

Encephale. 2006 May-Jun;32(3 Pt 1):341-50. Review. French.

PMID:
16840928
7.

Subjective well-being of patients with schizophrenia as a target of drug treatment.

Karamatskos E, Mulert C, Lambert M, Naber D.

Curr Pharm Biotechnol. 2012 Jun;13(8):1490-9. Review.

PMID:
22283757
8.

[Dopamine D2 and serotonin 5HT2 receptors: functions, interactions and clinical consequences in schizophrenia].

Guise S, Soubrouillard C, Blin O.

Encephale. 1997 Apr;23 Spec No 2:10-6. Review. French.

PMID:
9273300
9.

Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging.

Howes OD, Egerton A, Allan V, McGuire P, Stokes P, Kapur S.

Curr Pharm Des. 2009;15(22):2550-9. Review.

10.

Limbic circuits and monoamine receptors: dissecting the effects of antipsychotics from disease processes.

Joyce JN, Goldsmith SG, Gurevich EV.

J Psychiatr Res. 1997 Mar-Apr;31(2):197-217. Review.

PMID:
9278186
11.

Current use of atypical antipsychotics.

Müller-Spahn F.

Eur Psychiatry. 2002 Aug;17 Suppl 4:377s-384s. Review.

PMID:
23573608
12.
13.

Can antipsychotic treatment contribute to drug addiction in schizophrenia?

Samaha AN.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jul 3;52:9-16. doi: 10.1016/j.pnpbp.2013.06.008. Epub 2013 Jun 20. Review.

PMID:
23793001
14.

Antipsychotic efficacy: relationship to optimal D2-receptor occupancy.

Pani L, Pira L, Marchese G.

Eur Psychiatry. 2007 Jul;22(5):267-75. Epub 2007 Apr 6. Review.

PMID:
17419008
15.

[Recent developments in antipsychotic medication].

Möller HJ.

Schweiz Arch Neurol Psychiatr. 1995;146(5):230-9. Review. German.

PMID:
8658104
16.

Novel pharmacological approaches to the treatment of schizophrenia.

Fink-Jensen A.

Dan Med Bull. 2000 Jun;47(3):151-67. Review.

PMID:
10913983
17.

Conventional versus novel antipsychotics: changing concepts and clinical implications.

Remington G, Chong SA.

J Psychiatry Neurosci. 1999 Nov;24(5):431-41. Review.

18.
19.

Preclinical findings with new antipsychotic agents: what makes them atypical?

Jackson DM, Ryan C, Evenden J, Mohell N.

Acta Psychiatr Scand Suppl. 1994;380:41-8. Review.

PMID:
7914047
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk